Bio-MEMS eye sensor for continuous monitoring of intraocular pressure

青光眼是由眼内压（IOP）升高引起的可预防性失明的主要原因，在60岁以上人群中尤其普遍。目前监测和预防青光眼相关失明的治疗方法是通过滴眼液、激光治疗或手术降低IOP。该项目通过确保独立性和生活质量，同时降低长期医疗和社会成本，直接造福于我们的老龄化人口。通过将纳米技术与眼科学相结合，我们将为长期、可靠的家庭眼压监测提供一种经济的解决方案。植入式IOP传感器将识别需要更多侵入性治疗的患者，而不是侵袭性较低的患者，从而更好地利用卫生资源。

Glaucoma is a leading cause of preventable blindness, particularly prevalent in the 60+ population, caused by elevated intraocular pressure (IOP). Current treatment to monitor and prevent glaucoma-related blindness is by lowering IOP with eye-drops, laser therapy or surgery. This project directly benefits our aging population by ensuring independence and quality of life, whilst reducing long-term medical and social costs. By incorporating nanotechnology with ophthalmology we will provide an economic solution to long-term, reliable, home-monitoring of IOP. An implantable IOP sensor, will identify patients requiring more invasive treatment compared with those with less aggressive disease, leading to better health resource utilisation.